about
Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-studyImpacts of MR spectroscopic imaging on glioma patient management.Preprocessing of NMR metabolomics data.Bioactive compounds in cod (Gadus morhua) products and suitability of 1H NMR metabolite profiling for classification of the products using multivariate data analyses.Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dual-band suppression for metabolic mapping over the entire brain.Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomasMetabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.Merging transcriptomics and metabolomics--advances in breast cancer profiling.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene ExpressionIn vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgerySpermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.Metabolic changes in psoriatic skin under topical corticosteroid treatmentMetabolic characterization of triple negative breast cancer.Metabolomic biomarkers in serum and urine in women with preeclampsiaGene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopyIdentification of metabolites from 2D (1)H-(13)C HSQC NMR using peak correlation plotsA Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate CancerFirst Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening StudyIdentification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRSHigh-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence.Metabolic profiles of brain metastases.Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesPresence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.A novel non-canonical Wnt signature for prostate cancer aggressiveness.Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation.HR MAS MR spectroscopy in metabolic characterization of cancer.Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma.2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping.Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI.
P50
Q28481679-DA029273-A295-448B-813F-B13FCBB8E107Q30777660-CC350C61-9A61-4DCD-AC85-CE2125B85039Q30903618-B010B48C-6816-483B-9AFC-2635CFD6EBB6Q31000275-76D4387C-3436-4A02-9357-6B5324CD6E39Q31042659-39C4E33F-7072-4EC6-9DC2-E282739E78CEQ33269605-9BD3F693-F8C2-4B43-9B9E-2451664AB2F3Q33292251-CE7BBF74-570F-4512-993B-009EDEF854F0Q33748176-9B95DEDA-E290-4859-9AC1-C2353A6D06B8Q33844930-8398A0A1-4620-4BEF-B90E-4EFC57B3DC8CQ34016780-AACADCD7-9581-457D-BFEE-6C51A983CDCFQ34041364-EB453BCB-0743-4926-B4B3-350046FA67C2Q34101555-D0162F71-3C99-440C-B085-59822BB074EBQ34140986-C4D1828A-DA6B-4D46-903B-E1EEF112E517Q34684585-E2C95F7F-7DB8-45F0-AE53-E0152C14F43EQ34693066-20492D64-DD7D-4C29-97F1-1079D201A89DQ34941232-9EA0E4CB-D4D4-40D2-B6C6-24485D9C7693Q34967995-8F0866D9-5340-478E-8627-D4C9B60A4874Q35122808-E9824505-3978-4F0E-85D9-0559833A94D1Q35223291-94F2D05A-1E44-4876-9540-9DA6D9D54350Q35497704-9014F777-707F-4A41-9E8F-C6B13A3A49C3Q35522894-EE66F3AB-C763-4125-9596-70DAA8EC203BQ35996026-66CA97BE-3669-4717-B60E-C153B4E93EF8Q36184116-4990B83C-DC62-438C-8003-787E9DDAA842Q36309599-3E389587-2254-440E-A753-4311AF30604EQ36410307-0F81182E-CBC3-42D2-A5E7-AF9077E02C50Q36590191-F7CD9F48-C507-49F1-BF25-191C610FD646Q36649292-2896F154-F6B8-4FE3-806A-9F519A6964F3Q36680439-52F6BCB2-1988-4C08-A36D-BD9F6B62758BQ37040438-BE9757DD-4A0F-4603-AF76-54171AF6FCAAQ37520447-11B24278-8EE8-466E-8A25-BD45C1CAFB58Q37689772-7C0F94BF-6A80-497D-9EEF-1684007F7373Q37706021-FE5DAE6F-1C77-449A-AE43-398DA6E7C8B5Q37728699-874C1D49-3E05-4917-BCDD-4F453088BB5EQ37779171-6CA7E879-946E-43DF-9433-D05BD321698CQ37784533-E3FFAFD9-CBCD-4397-9567-1C6EAE0DEC90Q38598175-20E4E58A-D60D-49BA-AFD3-A07E66168E50Q38976997-B0B71808-FC94-4BC5-B2D0-DC6C79582BCDQ39382153-1FF35D34-9B63-41AE-AF1A-960C64DB96D0Q39817719-8E976241-2EA3-4156-B555-BB39503E3509Q40010957-BDB3390A-A69A-4595-9E2E-3201D37EFB62
P50
description
Noors onderzoekster
@nl
Norwegian professor
@en
norsk professor
@nb
ollamh Ioruach
@ga
name
Tone F Bathen
@ast
Tone F Bathen
@es
Tone F Bathen
@nl
Tone F Bathen
@sl
Tone F. Bathen
@da
Tone F. Bathen
@de
Tone F. Bathen
@en
Tone F. Bathen
@fr
Tone F. Bathen
@ga
Tone F. Bathen
@nb
type
label
Tone F Bathen
@ast
Tone F Bathen
@es
Tone F Bathen
@nl
Tone F Bathen
@sl
Tone F. Bathen
@da
Tone F. Bathen
@de
Tone F. Bathen
@en
Tone F. Bathen
@fr
Tone F. Bathen
@ga
Tone F. Bathen
@nb
altLabel
Tone Bathen
@nb
Tone F Bathen
@en
Tone Frost Bathen
@nb
prefLabel
Tone F Bathen
@ast
Tone F Bathen
@es
Tone F Bathen
@nl
Tone F Bathen
@sl
Tone F. Bathen
@da
Tone F. Bathen
@de
Tone F. Bathen
@en
Tone F. Bathen
@fr
Tone F. Bathen
@ga
Tone F. Bathen
@nb
P21
P214
1366149198209374940006
P2287
P27
P31
P496
0000-0002-8582-6965
P735
P7859
viaf-1366149198209374940006